Anzeige
Mehr »
Montag, 01.12.2025 - Börsentäglich über 12.000 News
MONSTER VON MAROKKO: AYA liefert die stärksten Bohrergebnisse seiner Geschichte - und dieser 3-Mrd-Dollar-Silberproduzent steigt jetzt in eine neue Liga auf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 882803 | ISIN: DK0010253921 | Ticker-Symbol: 5RF
Frankfurt
01.12.25 | 08:12
81,00 Euro
+0,62 % +0,50
1-Jahres-Chart
SCHOUW & CO A/S Chart 1 Jahr
5-Tage-Chart
SCHOUW & CO A/S 5-Tage-Chart
RealtimeGeldBriefZeit
80,3081,0011:39
GlobeNewswire (Europe)
37 Leser
Artikel bewerten:
(0)

Aktieselskabet Schouw & Co.: BioMar preliminary financial outlook for 2026 and mid-term targets

BioMar preliminary financial outlook for 2026 and mid-term targets

On 12 November 2024, the Board of Directors of Schouw & Co. announced the initiation of an evaluation regarding a potential separate listing of BioMar. The objective of this assessment is to determine whether such a listing would generate added value for Schouw & Co. and its shareholders, while simultaneously ensuring that BioMar is well positioned to pursue opportunities for continued growth.

The evaluation is progressing as expected. Schouw & Co. is assisted by a syndicate comprising four financial institutions: DNB Carnegie and Morgan Stanley as Lead Joint Global Coordinators, and Danske Bank and Nordea as Joint Global Coordinators. FIH Partners acts as independent IPO advisor to Schouw & Co. and BioMar.

As part of the preparation towards a potential separate listing of BioMar on Nasdaq Copenhagen, which could take place in the first half of 2026, the Board of Directors of Schouw & Co. has evaluated BioMar's short-term and mid-term outlook and has decided to disclose selected preliminary information.

MetricOutlook 2026Comments
Volume1,600-1,670 thousand tonnesVolumes expected to grow 2-7% in 2026 compared to 2025
RevenueDKK 16,000-17,000 millionBased on foreign exchange rates and raw material prices at current levels
EBITDKK 1,100-1,200 millionDepreciation and amortisation in the level of DKK 400 million
CapexDKK 300-500 millionAbove historical levels. Depends on timing of a potential expansion in Ecuador of c. DKK 250 million

'Towards 2030, BioMar aims to achieve a volume growth of an average of 4-6% per annum while EBIT is targeted to grow at an average rate of 8-10% per annum. ROIC incl. goodwill is targeted to be above 20%.

As a potentially independently listed company, BioMar targets a capital structure in the range of 1.0-2.0 times net interest-bearing debt to EBITDA and a dividend policy aiming for a payout of at least 50% of annual net profit.

All the above-mentioned figures are preliminary and subject to change. Schouw & Co. releases its annual report for 2025 on 5 March 2026, in which the outlook for Schouw & Co. and the remaining portfolio companies will be disclosed.

Aktieselskabet Schouw & Co.

Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, tel. +45 8611 22 22


© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.